Table 1.
Demographics
| N=89 (%) | |
|---|---|
| Gestational age, weeks | |
| ≤25 | 5 (6) |
| 26–28 | 8 (9) |
| 29–32 | 25 (28) |
| 33–36 | 14 (16) |
| ≥37 | 37 (42) |
| Birth weight, g | |
| <1000 | 9 (10) |
| 1000–1499 | 14 (16) |
| 1500–2499 | 28 (31) |
| 2500–3499 | 28 (31) |
| ≥3500 | 10 (11) |
| Apgar score at 5 minutes | |
| 0–3 | 1 (1) |
| 4–6 | 11 (13) |
| 7–10 | 74 (86) |
| Race/ethnicity | |
| White | 45 (52) |
| African-American | 26 (30) |
| Hispanic | 14 (16) |
| Other | 1 (1) |
| Male | 43 (48) |
| Inborn | 69 (78) |
| Cesarean section | 40 (45) |
| Small for gestational age | 8 (9) |
| Source of HSV diagnosis | |
| Clinical diagnosis | 45 (51) |
| Virologic diagnosis | 44 (49) |
| Age at 1st acyclovir dose, days | |
| <7 | 58 (66) |
| 7–13 | 19 (22) |
| 14–28 | 10 (11) |
| >28 | 1 (1) |
| Duration of therapy, days | 18 (15, 22)* |
*
median (25th, 75th percentile)